[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fsgu94DLBIkLwAYSH1dqDMZRwrGowxOx6nSwAY4jloxM":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":38,"rows":45},"University Hospital of Cologne",[4],41,false,12,0,10200487,1,36,[14,17,20,22,24,26,28,30],{"name":15,"count":16},"Allergic Rhinitis",3,{"name":18,"count":19},"Cardiac Arrest",2,{"name":21,"count":19},"Invasive Aspergillosis",{"name":23,"count":19},"VRE Infection",{"name":25,"count":11},"Newborn",{"name":27,"count":11},"Posterior Maxilla Edentulous Patients With Insufficient Alveolar Bone Height",{"name":29,"count":11},"NAFLD; Hypertension, White-coat Hypertension, Masked Hypertension",{"name":31,"count":11},"Patients at High Risk of Antibacterial Treatment Upon Admission",[33],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT01821456","Cologne Cohort of Neutropenic Patients (CoCoNut)","2050-12","Antiinfectives",[39,40,41,42,43,44],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[46,72,97,124,149],{"intervention":37,"totalTrials":11,"cells":47},{"EARLY_PHASE1":48,"PHASE1":50,"PHASE2":52,"PHASE3":54,"PHASE4":56,"NA":58},{"trials":49,"activeCount":9},[],{"trials":51,"activeCount":9},[],{"trials":53,"activeCount":9},[],{"trials":55,"activeCount":9},[],{"trials":57,"activeCount":9},[],{"trials":59,"activeCount":11,"soonestReadout":36},[60],{"nctId":34,"briefTitle":35,"status":61,"phases":62,"primaryCompletion":36,"completion":36,"start":63,"enrollment":64,"conditions":65,"interventions":71},"RECRUITING",[],"1995-01",100000,[66,67,68,69,70],"Hematological Malignancies","Cancer","Chemotherapy","Neutropenia","Immunosuppression",[37],{"intervention":73,"totalTrials":11,"cells":74},"Sublingual Immunotherapy with",{"EARLY_PHASE1":75,"PHASE1":77,"PHASE2":79,"PHASE3":81,"PHASE4":83,"NA":85},{"trials":76,"activeCount":9},[],{"trials":78,"activeCount":9},[],{"trials":80,"activeCount":9},[],{"trials":82,"activeCount":9},[],{"trials":84,"activeCount":9},[],{"trials":86,"activeCount":9},[87],{"nctId":88,"briefTitle":89,"status":90,"phases":91,"primaryCompletion":92,"completion":92,"start":93,"enrollment":94,"conditions":95,"interventions":96},"NCT02609581","Tolerability of SLIT With LAIS® Mites Allergoid Tablets","COMPLETED",[],"2017-02-28","2015-12-01",192,[15],[73],{"intervention":98,"totalTrials":11,"cells":99},"Oxygen",{"EARLY_PHASE1":100,"PHASE1":102,"PHASE2":104,"PHASE3":106,"PHASE4":108,"NA":110},{"trials":101,"activeCount":9},[],{"trials":103,"activeCount":9},[],{"trials":105,"activeCount":9},[],{"trials":107,"activeCount":9},[],{"trials":109,"activeCount":9},[],{"trials":111,"activeCount":9},[112],{"nctId":113,"briefTitle":114,"status":115,"phases":116,"primaryCompletion":117,"completion":118,"start":119,"enrollment":120,"conditions":121,"interventions":123},"NCT02553668","Proteomics for Identification of Hyperoxia-induced Changes in Protein Expression","UNKNOWN",[44],"2016-10","2016-12","2015-10",40,[122],"Hyperoxia",[98],{"intervention":125,"totalTrials":11,"cells":126},"Acarovac",{"EARLY_PHASE1":127,"PHASE1":129,"PHASE2":131,"PHASE3":133,"PHASE4":135,"NA":137},{"trials":128,"activeCount":9},[],{"trials":130,"activeCount":9},[],{"trials":132,"activeCount":9},[],{"trials":134,"activeCount":9},[],{"trials":136,"activeCount":9},[],{"trials":138,"activeCount":9},[139],{"nctId":140,"briefTitle":141,"status":90,"phases":142,"primaryCompletion":143,"completion":143,"start":144,"enrollment":145,"conditions":146,"interventions":148},"NCT03127436","Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe",[],"2019-02-14","2017-03-01",32,[147],"Perennial Allergic Rhinitis",[125],{"intervention":150,"totalTrials":11,"cells":151},"ORALVAC COMPACT BÄUME",{"EARLY_PHASE1":152,"PHASE1":154,"PHASE2":156,"PHASE3":158,"PHASE4":160,"NA":162},{"trials":153,"activeCount":9},[],{"trials":155,"activeCount":9},[],{"trials":157,"activeCount":9},[],{"trials":159,"activeCount":9},[],{"trials":161,"activeCount":9},[],{"trials":163,"activeCount":9},[164],{"nctId":165,"briefTitle":166,"status":90,"phases":167,"primaryCompletion":168,"completion":168,"start":169,"enrollment":170,"conditions":171,"interventions":173},"NCT03097432","Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy Treatment",[],"2017-10-19","2016-10-20",164,[172],"Seasonal Allergic Rhinitis",[150]]